PML is upregulated in metastatic breast cancer and non-metastatic breast cancer with a poor prognosis, and studies indicate that PML may be involved in expression of the stem cell factor SOX9 and associated initiation of breast cancer (37). The gene discussed is SOX9; the disease is breast cancer.